0

Home > Drug Category > Anti-Malarial > Qualaquin and Equivalent

Qualaquin (Quinine Sulphate) Information

Qualaquin (quinine sulphate) is an alkaloid derived from the bark of the cinchona tree. It is a traditional and powerful antimalarial agent, specifically indicated only for the treatment of uncomplicated malaria caused by drug-resistant Plasmodium falciparum strains. The drug carries an FDA Boxed Warning due to the risk of serious and life-threatening adverse effects, and its use is strictly limited to this single, approved indication. It is not approved for the prevention of malaria and, due to significant risks, is strictly contraindicated for the treatment or prevention of nocturnal leg cramps. Qualaquin is typically supplied as a 324 mg oral capsule and is almost always used in combination with a second antimalarial drug (often an antibiotic like doxycycline or clindamycin) to ensure a complete cure and prevent recurrence. The standard adult dosing regimen is 648 mg every 8 hours for 7 days, and it should be taken with food to minimize gastrointestinal upset.

The precise mechanism of action for quinine is not fully understood. However, it is believed to be similar to that of chloroquine. It acts as a blood schizonticide, targeting the asexual parasites circulating in the red blood cells that cause the acute, symptomatic phase of malaria. Quinine is a weak base that concentrates within the acidic food vacuole of the parasite. Here, it is thought to interfere with the parasite’s ability to detoxify the toxic byproduct of hemoglobin digestion, heme, by preventing its polymerization into non-toxic hemozoin. The resulting accumulation of poisonous heme is lethal to the parasite. The hepatic cytochrome P450 enzyme CYP3A4 primarily metabolizes quinine.

Qualaquin Side Effects

Quinine can cause a cluster of side effects known as cinchonism, which occurs to some degree in nearly all patients. Common side effects associated with mild cinchonism include headache, sweating, nausea, tinnitus (ringing in the ears), dizziness or vertigo, and blurred vision. Other common effects are vomiting, diarrhea, and stomach pain.

However, more serious side effects can occur. If any of the following symptoms are experienced, the patient should stop taking the medication and seek immediate medical attention:

• Acute Hypoglycemia (Low Blood Sugar): Quinine stimulates the release of insulin from the pancreas and can cause severe, sometimes life-threatening low blood sugar, even in patients without a history of diabetes, particularly in pregnant women and those with severe malaria. Symptoms include cold sweats, anxiety, confusion, and loss of consciousness.

• Cardiac Arrhythmias (Boxed Warning): Quinine can cause dose-related and unpredictable prolongation of the QT interval, leading to severe, potentially fatal ventricular arrhythmias, including Torsades de Pointes.

• Hematologic Reactions (Boxed Warning): Severe, life-threatening blood disorders, including Thrombotic Microangiopathy (such as Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura (HUS/TTP)) and thrombocytopenia (low platelets), have been reported, which can lead to fatal hemorrhage.

• Hypersensitivity Reactions (Boxed Warning): Severe allergic reactions, including anaphylaxis and severe cutaneous reactions (e.g., Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis), have been reported, often accompanied by fever and rash.

• Neuromuscular Effects: Quinine possesses neuromuscular blocking activity and can significantly exacerbate conditions such as myasthenia gravis.

• Ocular/Ototoxicity (Cinchonism): Severe cinchonism can cause permanent hearing loss, deafness, and vision disturbances, including permanent blindness and changes in colour perception.

Qualaquin Precautions

Given the severe risks and Boxed Warning, Qualaquin is reserved only for its approved indication and requires close medical supervision with prompt discontinuation upon any sign of severe hematologic, cardiac, or hypersensitivity reactions. It is strictly contraindicated in patients with a history of hypersensitivity to quinine or related compounds (quinidine or mefloquine), known QT prolongation or other severe cardiac conditions (e.g., heart block), and a history of TTP/HUS or thrombocytopenia associated with prior quinine use. Extreme caution is necessary in patients with existing atrial fibrillation or flutter due to the risk of increasing the ventricular response rate. Before treatment is initiated, patients require an Electrocardiogram (ECG) and monitoring of serum electrolytes (like potassium) to assess cardiac risk. They should also be tested for Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency to rule out the risk of acute, life-threatening hemolysis. CYP3A4 predominantly metabolizes quinine. Therefore, it is contraindicated for concurrent use with numerous other medications that prolong the QT interval (such as dronedarone) or are potent inhibitors of CYP3A4 (such as certain antifungals or HIV medications), as this combination dramatically raises quinine concentrations and the risk of cardiotoxicity.

Do I need a prescription to order Qualaquin?

Yes, a prescription is required from your physician to order Qualaquin.